» Authors » Massimo Nicolo

Massimo Nicolo

Explore the profile of Massimo Nicolo including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 71
Citations 490
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Puddu A, Nicolo M, Maggi D
Int J Mol Sci . 2025 Feb; 26(4). PMID: 40003961
Oxidative stress is considered a common underlying mechanism in many retinal degenerative diseases and is often associated with inflammation. The use of dietary supplements containing has beneficial effects in ocular...
2.
Parravano M, Viola F, Nicolo M, Vujosevic S, Bianchino L, Sicari E, et al.
Eur J Ophthalmol . 2025 Feb; :11206721241310628. PMID: 39901532
Purpose: Age-related macular degeneration (AMD) is a leading cause of irreversible vision loss, particularly neovascular AMD (nAMD). This study aimed to investigate the real-world treatment patterns, effectiveness, and safety of...
3.
Forte P, Paques M, Cattaneo J, Dupas B, Castro-Farias D, Girmens J, et al.
Surv Ophthalmol . 2025 Jan; 70(3):369-379. PMID: 39824296
Focal capillary ectasia in the macular region can manifest in distinct clinical scenarios, which can be categorized into 2 main entities: perifoveal vascular anomalous complex (PVAC) and telangiectatic capillaries (TelCaps)....
4.
Feo A, Stradiotto E, Govetto A, Forte P, Boscia G, Nicolo M, et al.
Surv Ophthalmol . 2025 Jan; 70(3):401-411. PMID: 39818360
Bacillary layer detachment (BALAD) refers to the distinctive splitting at the level of the photoreceptor inner segment myoid and accumulation of intraretinal fluid, as seen on optical coherence tomography (OCT). ...
5.
Forte P, Feo A, Sarraf D, Romano M, Nicolo M
Eye (Lond) . 2024 Dec; 39(3):449-459. PMID: 39702788
The aim of this article is to comprehensively review the multimodal imaging (MMI) features that define perifoveal vascular anomalous complex (PVAC) and to update the optimal treatment strategies for this...
6.
Galeone C, Turati F, Nicolo M, Parravano M, Vujosevic S, Bianchino L, et al.
Drug Target Insights . 2024 Dec; 18:105-111. PMID: 39677855
Objectives: To assess through an indirect treatment comparison (ITC) the potential benefit of faricimab over the anti-vascular endothelial growth factor (VEGF) real-life scenario, hereby defined standard of care (SoC), in...
7.
Sacconi R, Forte P, Corradetti G, Costanzo E, Capuano V, Bousquet E, et al.
Ophthalmol Retina . 2024 Nov; PMID: 39566885
Purpose: To identify baseline OCT predictors of the 3-year macular atrophy (MA) development for type 3 (T3) macular neovascularization (MNV) secondary to neovascular age-related macular degeneration (nAMD) treated by anti-VEGF...
8.
Samanta A, Gregori G, Muzi A, Gujar R, Mariotti C, Fruttini D, et al.
J Clin Med . 2024 Nov; 13(21). PMID: 39518719
: The aim of this study was to evaluate the choroidal vascular response using optical coherence tomography (OCT) in patients with chronic central serous chorioretinopathy (CSCR) during transient increases in...
9.
Forte P, Cattaneo J, Cardillo Piccolino F, Arrigo A, Corazza P, Musetti D, et al.
Acta Ophthalmol . 2024 Oct; PMID: 39428607
Purpose: To test the prognostic role of anterior scleral substantia propria (ASSP) thickness in predicting the 3-month response after half-dose photodynamic therapy (PDT) in central serous chorioretinopathy (CSCR) and to...
10.
Borrelli E, Coco G, Pellegrini M, Mura M, Ciarmatori N, Scorcia V, et al.
Ophthalmol Ther . 2024 Sep; 13(11):2855-2868. PMID: 39271642
Introduction: Photobiomodulation (PBM) has become a promising approach for slowing the progression of early and intermediate dry age-related macular degeneration (dAMD) to advanced AMD. This technique uses light to penetrate...